Preview

Osteoporosis and Bone Diseases

Advanced search

DENOSUMAB IN THE TREATMENT OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RESULTS OF 2-YEAR FOLLOW-UP)

About the Authors

O. V. Dobrovolskaya
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



P. S. Kovalenko
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



N. V. Demin
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



N. V. Toroptsova
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



I. S. Dydykina
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



O. A. Nikitinskaya
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



E. L. Nasonov
Ministry of Science and Higher Education; Research Institute of Rheumatology named after V.A. Nasonova
Russian Federation

Moscow



Review

For citations:


Dobrovolskaya O.V., Kovalenko P.S., Demin N.V., Toroptsova N.V., Dydykina I.S., Nikitinskaya O.A., Nasonov E.L. DENOSUMAB IN THE TREATMENT OF OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RESULTS OF 2-YEAR FOLLOW-UP). Osteoporosis and Bone Diseases. 2020;23(1):107. (In Russ.)

Views: 188


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)